The results of the present study are 2-fold: (1) Despite evaluating a number of different biomarkers to assess drug efficacy, RSV at the dose and route of administration used here (i.e., 120 mg/kg/day; orally in the chow) showed no beneficial effect in SOD1-G93A ALS mice. Here, SOD1 is linked to amyotrophic lateral sclerosis.